跳至主要内容
临床试验/ACTRN12617000566336
ACTRN12617000566336已完成未知

A pilot comparative evaluation of the haemodynamic and electrolyte effects of Frusemide and Acetazolamide in critically ill patients

Austin Health0 个研究点目标入组 24 人开始时间: 2017年4月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
Austin Health
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Admission to the Austin Hospital ICU
  • Age 18 years or greater
  • An attending physician’s decision to administer a diuretic
  • An anticipated ICU length of stay of >24 hours after frusemide administration
  • Patients with existing intra-arterial cannulae or central venous catheters for blood sampling, and indwelling urinary catheters.

排除标准

  • Patients with known allergy to frusemide or acetazolamide or other sulphonamides.
  • Known existing end stage renal failure
  • Long-standing use of diuretic therapy
  • Dose of different diuretic in the preceding 12 hours.
  • Significant pre-existing acid-base disturbance at time of enrolment (pH < 7.30 or > 7.50)
  • Patient receiving continuous renal-replacement therapy

研究者

发起方
Austin Health

相似试验